AP control of as the most efficacious tool for the prevention of cardiovascular complications in patients with type 2 diabetes mellitus
Эксперты прогнозируют значительный рост заболеваемости СД2 в ближайшие 10?15 лет. Неблагоприятный прогноз у этих больных определяется высоким риском развития кардио- и цереброваскулярных осложнений. Применение фиксированной комбинации периндоприла с индапамидом (нолипрел) у больных СД2 независимо от...
Saved in:
Main Author: | Yury Alexandrovich Karpov |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/d36e35a4d5d64965bd734b54dd41ee0d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tasks and objectives of the ADVANCE study. Design of the study. Rationale for the use of diabeton MB
by: Olga Mikhailovna Smirnova
Published: (2009) -
Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
by: Olga Konstantinovna Vikulova
Published: (2012) -
Specific features of pregnancy in patients with type 1 diabetes in the prepubertal period. Results of a 15-year long clinical observation
by: Lyubov' Leonidovna Bolotskaya, et al.
Published: (2009) -
Epidemiological characteristics of diabetes mellitus and its complications in the Omsk region
by: Marina Lukmanovna Sayfullina, et al.
Published: (2010) -
Age and sex-related variations in the time of manifestation of type 1 diabetes mellitus and its chronic complications in children
by: Oleg Avgustovich Dianov, et al.
Published: (2010)